drugset / Trial / NCT02529579
Safety and Efficacy Evaluation of iAPA-DC/CTL Combined Gemcitabine Therapy on Advanced Pancreatic Cancer
RandomizedParallel-groupSingle-blindTreatment
Summary
The aim of this study is to evaluate the safety and efficacy of iAPA-DC/CTL combined gemcitabine therapy on advanced pancreatic cancer.
Timeline
- Start
- 2015-06
- Primary completion
- 2018-12
- Completion
- 2019-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | iAPA-DC/CTL | Cell therapy | — | — |
| Background | Gemcitabine | Small molecule | — | — |